Ocular toxoplasmosis in immunocompetent adults: current cost-effectiveness of four treatment regimens in Colombia.

Álvarez-García, Valentina; Rubio-Romero, Lorena; Maldonado, María Alejandra; Gómez-Suárez, Marcela; de-la-Torre, Alejandra

Álvarez-García, Valentina; Rubio-Romero, Lorena; Maldonado, María Alejandra; Gómez-Suárez, Marcela; de-la-Torre, Alejandra.

Affiliation

Álvarez-García V; Neuroscience Research Group (NEUROS), Neuroscience Center (NeuroVitae), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Colombia.
Rubio-Romero L; Neuroscience Research Group (NEUROS), Neuroscience Center (NeuroVitae), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Colombia.
Maldonado MA; Neuroscience Research Group (NEUROS), Neuroscience Center (NeuroVitae), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Colombia.
Gómez-Suárez M; Universidad Nacional de Colombia, Doctorado Interfacultades en Salud Pública, Facultad de Medicina, Grupo de Equidad en Salud, Colombia.
de-la-Torre A; Neuroscience Research Group (NEUROS), Neuroscience Center (NeuroVitae), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Colombia.

Heliyon ; 7(11): e08265, 2021 Nov.

Article in En | MEDLINE | ID: mdl-34778574

Key words

Cost-analysis; Costs; Immunocompetent patients; Latin America; Ocular toxoplasmosis; Therapeutic failure; Therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Country/Region as subject: America do sul / Colombia Language: En Journal: Heliyon Year: 2021 Document type: Article Affiliation country: Colombia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google